# PreFER Managed Ventricular Pacing (MVP) For Elective Replacement

> **NCT00293241** · PHASE4 · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 630 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DEVICE:** Managed Ventricular Pacing programmed ON/OFF

## Key facts

- **NCT ID:** NCT00293241
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 630 (ACTUAL)
- **Last updated:** 2016-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293241, "PreFER Managed Ventricular Pacing (MVP) For Elective Replacement". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00293241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*